Timo Soininen Welcomes Nightingale as Chairman of the Board

Timo Soininen Welcomes Nightingale as Chairman of the Board

Healthcare Tech Outlook | Tuesday, December 29, 2020

Timo Soininen is one of Europe’s most prolific serial entrepreneurs, a digital marketing specialist, and an involved growth investor.

FREMONT, CA: Nightingale Health, a healthcare technology firm, has reported that Timo Soininen, co-founder and former CEO of Small Giant Games, has joined the company as Chairman of the Board. This occasion is a very significant development for Nightingale. After a long five-year R&D period, the company is now rapidly expanding the global commercial B2B and B2C operations of its health data platform as exploring the potential of an IPO in the coming months.

“We are thrilled to have Timo join us. His vast experience in building consumer-centric companies in the digital world will play a key role in Nightingale’s next phase of growth, as we aim to build a more sustainable, engaging and people-oriented preventive healthcare system,” added TeemuSuna, Founder, and CEO, Nightingale. 

Soininen is one of Europe’s most prolific serial entrepreneurs, a digital marketing specialist, and an involved growth investor. He is the co-founder and former CEO of Small Giant Games, one of the fastest-growing social gaming firms globally. Under the leadership of Soininen, Small Giant Games increased its revenue from zero to EUR 328 million in three years. In December 2018, Zynga purchased 80 percent of the company for 700 million dollars.

“Nightingale’s health data platform has a leading-edge in the global megatrend of consumers wanting to manage and improve their health. It’s a privilege to join Nightingale’s exceptional team and work together towards establishing Nightingale’s technology as the new global standard for preventive health,” said Timo Soininen, Chairman of the Board, Nightingale.

Building Sustainable Preventive Care

The Nightingale health data platform is a rare combination of pioneering blood testing technologies and the potential to use blood-based data to detect possible disease risks. “Next, our goal is to utilize the platform’s capabilities to establish foundations for a primary care system that helps prevent diseases by equipping people with better information about their health,” said Suna.

This new framework is becoming part of people’s everyday lives by linking them to tailored preventive health services and better-taking care of themselves through Nightingale’s health perspectives and continuous feedback. “The ongoing global COVID-19 crisis has demonstrated that the current healthcare operations will break if there is a significant increase in the number of people falling sick. The solution is, therefore, to build a parallel health system that specialises in disease prevention. Effective disease prevention together with treatment care, will create a healthier world,” added Suna.

IPO on the Horizon 

This global expansion and the commercial roll-out process need to be funded by competitive financing solutions. Therefore, Nightingale has recently named Swedbank AB (publ), the Finnish Branch, as the leading financial advisor, to explore various options, including prospects for an Initial Public Offering, by listing the shares of Nasdaq Helsinki First North. “The goal is to make Nightingale a major international growth company over the next five years by collaborating with the existing health industry and placing solutions that improve people’s health at the heart of our expansion strategy,” said Suna.

Weekly Brief